What You Will Learn in This Article
- The classical definition of essential fatty acids and which ones qualify
- The omega-3 and omega-6 fatty acid families — structures, naming, and metabolic fates
- Why DHA is specifically critical for infant brain and retinal development
- The biochemical pathway from dietary precursors (ALA → DHA; LA → AA)
- The composition of breast milk fat — what’s in it and why it matters
- Deficiency syndromes of essential fatty acids and their clinical features
- How formula manufacturers attempt to replicate breast milk’s fatty acid profile
- High-yield exam facts, mnemonics, and common traps on this topic
📖 Introduction: Why This Topic Matters in Exams
The human brain undergoes its most explosive period of growth in the last trimester of pregnancy and the first two years of life. During this window, the brain nearly triples in size. Grey matter accumulates. Synaptic connections multiply at a rate of approximately one million per second. Myelin sheaths wrap around axons, enabling fast nerve conduction.
All of this requires fat — specifically, the right kind of fat.
Approximately 60% of the dry weight of the human brain is lipid, and the most abundant structural fatty acid in the cerebral cortex and the photoreceptors of the retina is docosahexaenoic acid (DHA). A newborn infant cannot synthesise DHA efficiently from precursors, and so it must be provided preformed — in breast milk.
This topic is tested in medical entrance examinations because it sits at the crossroads of biochemistry (fatty acid metabolism, desaturation, elongation), physiology (neonatal nutrition), and clinical medicine (breastfeeding recommendations, formula composition, fatty acid deficiency syndromes). It rewards integrated thinking rather than rote memorisation.
🔬 Section 1 — Essential Fatty Acids: Foundational Biochemistry
1A. What Makes a Fatty Acid “Essential”?
A fatty acid is classified as essential if:
- The human body cannot synthesise it de novo (from scratch)
- It is required for normal physiological function
- It must therefore be obtained from the diet
The body’s limitation comes from a key enzymatic gap: humans possess Δ9-desaturase (which can introduce a double bond at the 9th carbon) but lack Δ12-desaturase and Δ15-desaturase, which are needed to introduce double bonds beyond C9 toward the methyl (omega) end of the chain.
This means:
- Humans can make saturated fatty acids (palmitate, stearate) and monounsaturated fatty acids (oleic acid, 18:1Δ9) from acetyl-CoA
- Humans cannot make linoleic acid (18:2, Δ9,12) or alpha-linolenic acid (18:3, Δ9,12,15) — the two truly essential fatty acids
1B. The Two Truly Essential Fatty Acids
| Fatty Acid | Common Name | Family | Carbon:Double bonds | Key Function |
|---|---|---|---|---|
| Linoleic acid (LA) | — | Omega-6 | 18:2 (Δ9,12) | Precursor to arachidonic acid; skin barrier; eicosanoids |
| Alpha-linolenic acid (ALA) | — | Omega-3 | 18:3 (Δ9,12,15) | Precursor to EPA and DHA; brain/retina |
These two are the only fatty acids that are strictly essential in the classical biochemical definition. Everything else (arachidonic acid, EPA, DHA) can theoretically be synthesised from these precursors — but the efficiency of conversion is so poor (especially in neonates) that DHA and AA functionally behave as conditionally essential in infants.
1C. Fatty Acid Nomenclature — Reading the Numbers
Understanding how fatty acids are named is critical for exam questions:
Systematic notation: Carbon count : Number of double bonds (Δ position of double bonds)
| Notation | Name | Family |
|---|---|---|
| 18:0 | Stearic acid | Saturated |
| 18:1 Δ9 | Oleic acid | Omega-9 (non-essential) |
| 18:2 Δ9,12 | Linoleic acid | Omega-6 |
| 18:3 Δ9,12,15 | Alpha-linolenic acid | Omega-3 |
| 20:4 Δ5,8,11,14 | Arachidonic acid (AA) | Omega-6 |
| 20:5 Δ5,8,11,14,17 | EPA (Eicosapentaenoic acid) | Omega-3 |
| 22:6 Δ4,7,10,13,16,19 | DHA (Docosahexaenoic acid) | Omega-3 |
Omega (ω) nomenclature: The omega number tells you the position of the first double bond from the methyl (omega) end of the chain.
- Omega-3 = first double bond at the 3rd carbon from the methyl end
- Omega-6 = first double bond at the 6th carbon from the methyl end
🏥 Section 2 — The Omega-3 and Omega-6 Pathways: From Precursor to DHA
2A. The Omega-3 Pathway (ALA → EPA → DHA)
The conversion from dietary ALA (found in flaxseeds, walnuts, chia seeds) to the long-chain omega-3s requires a series of desaturation (adding double bonds) and elongation (adding 2-carbon units) steps — all occurring primarily in the endoplasmic reticulum of the liver:
Alpha-linolenic acid (ALA) 18:3 ω3
↓ Δ6-desaturase (rate-limiting step)
Stearidonic acid 18:4 ω3
↓ Elongase
Eicosatetraenoic acid 20:4 ω3
↓ Δ5-desaturase
EPA (Eicosapentaenoic acid) 20:5 ω3
↓ Elongase × 2 steps
Tetracosapentaenoic acid 24:5 ω3
↓ Δ6-desaturase
Tetracosahexaenoic acid 24:6 ω3
↓ β-oxidation (one cycle, in peroxisome)
DHA (Docosahexaenoic acid) 22:6 ω32B. The Omega-6 Pathway (LA → Arachidonic Acid)
The same desaturases and elongases act on linoleic acid:
Linoleic acid (LA) 18:2 ω6
↓ Δ6-desaturase (shared, rate-limiting)
Gamma-linolenic acid (GLA) 18:3 ω6
↓ Elongase
Dihomo-gamma-linolenic acid (DGLA) 20:3 ω6
↓ Δ5-desaturase
Arachidonic acid (AA) 20:4 ω6Critical point: Both pathways compete for the same Δ6-desaturase enzyme. This is why the ratio of omega-6 to omega-3 in the diet matters — a high omega-6:omega-3 ratio floods the enzyme with LA substrate, reducing DHA synthesis from ALA.
2C. Why Neonates Cannot Make Enough DHA
Δ6-desaturase activity is:
- Very low in premature infants
- Immature in full-term newborns
- Only approaches adult levels after the first few months of life
This enzymatic immaturity means that even if a formula-fed infant consumes adequate ALA, the conversion to DHA will be severely limited. This is the biochemical justification for:
- Breastfeeding as the gold standard of infant nutrition
- DHA supplementation of infant formula
🧪 Section 3 — DHA in Breast Milk: Composition and Significance
3A. The Fatty Acid Composition of Human Breast Milk
Human breast milk fat (~3.5–4.5 g/100 mL) is a sophisticated mixture:
| Fatty Acid | Approximate Content | Notes |
|---|---|---|
| Palmitic acid (16:0) | ~20–25% | Saturated; positioned at sn-2 of triglyceride — improves absorption |
| Oleic acid (18:1 ω9) | ~30–35% | Monounsaturated; energy substrate |
| Linoleic acid (18:2 ω6) | ~10–15% | Essential omega-6; precursor to AA |
| Alpha-linolenic acid (18:3 ω3) | ~1–2% | Essential omega-3; precursor to DHA |
| DHA (22:6 ω3) | ~0.2–0.5% | Critical for brain/retina |
| Arachidonic acid (20:4 ω6) | ~0.4–0.7% | Critical for brain/immune function |
Although DHA is present in small percentages by volume, its biological importance is disproportionate to its quantity. The concentration in breast milk varies with the mother’s diet — mothers who consume oily fish have significantly higher breast milk DHA levels.
3B. Why DHA Is Critical — The Biology of Brain Development
Brain structure: DHA constitutes ~15–20% of all fatty acids in the cerebral cortex. It is incorporated into the phospholipid bilayers of neuronal cell membranes — particularly phosphatidylethanolamine and phosphatidylserine. Its six double bonds make it the most flexible and fluid of all biological fatty acids, enabling:
- Optimal membrane fluidity at body temperature
- Efficient signal transduction (neurotransmitter receptor function)
- Rapid vesicle fusion and endocytosis at synapses
Retinal photoreceptors: DHA makes up ~50% of all fatty acids in photoreceptor outer segment membranes (the rods and cones). This extraordinary concentration underlies the visual acuity deficit seen in DHA-deficient infants.
Synaptogenesis: DHA promotes dendritic arborisation (branching of dendrites) and supports neurotrophic factor signalling (BDNF, NGF). DHA-derived molecules called protectins (neuroprotectins) have anti-inflammatory and neuroprotective effects.
Myelination: Adequate LC-PUFA supply supports the synthesis of myelin — the insulating sheath around axons — during the critical period of postnatal myelination.
3C. Evidence for DHA’s Role — Clinical Studies
Multiple randomised controlled trials have shown:
- Formula-fed infants supplemented with DHA have higher visual acuity scores at 2 months and 4 months compared to unsupplemented controls
- Breastfed infants (with naturally high DHA intake) show higher Bayley Mental Development Index scores than formula-fed infants in some studies
- Preterm infants (who miss the 3rd-trimester brain DHA accumulation period) have the greatest benefit from DHA supplementation
- DHA supplementation of lactating mothers raises breast milk DHA content dose-dependently
💊 Section 4 — Essential Fatty Acid Deficiency: Clinical Features and Management
4A. Classical EFA Deficiency Syndrome
Essential fatty acid deficiency is rare in adults on a normal diet but can occur in:
- Patients on prolonged total parenteral nutrition (TPN) with no fat emulsion
- Infants fed fat-free or very low-fat formulas (historical, now obsolete)
- Patients with fat malabsorption (cystic fibrosis, cholestatic liver disease, short bowel syndrome)
- Premature infants (relatively deficient due to immature synthesis and depleted stores)
Clinical features of EFA deficiency:
| Feature | Mechanism |
|---|---|
| Scaly dermatitis / ichthyosis-like rash | LA is essential for ceramide synthesis in the skin barrier; deficiency impairs the water-permeability barrier of the stratum corneum |
| Alopecia (hair loss) | Altered follicle membrane lipid composition |
| Poor wound healing | Impaired cell membrane synthesis; reduced eicosanoid production |
| Growth retardation | Reduced substrate for membrane synthesis; impaired GH signalling |
| Increased susceptibility to infection | Reduced prostaglandin-mediated immune responses |
| Thrombocytopenia | Reduced thromboxane A2 production |
| Impaired visual and cognitive development | DHA deficiency in retina and brain (especially in neonates) |
| Elevated Mead acid (20:3 ω9) | When EFA is absent, oleic acid (ω9) is desaturated/elongated to Mead acid as a substitute → ↑ Mead acid:arachidonic acid ratio (Holman ratio) > 0.4 is diagnostic |
4B. The Holman Ratio — A Diagnostic Tool
Holman Index = Mead acid (20:3 ω9) / Arachidonic acid (20:4 ω6)
- Normal: < 0.4
- EFA deficiency: > 0.4
When linoleic acid is deficient, the body uses oleic acid (ω9) as an alternative substrate for Δ6-desaturase and elongases, producing Mead acid. Mead acid cannot substitute functionally for AA or DHA, and its accumulation relative to AA signals EFA deficiency.
4C. Management
- Prevention in TPN patients: Add IV fat emulsion (Intralipid — 20% soybean oil emulsion rich in LA and ALA) to parenteral nutrition
- Preterm infants: DHA and AA supplementation of formula; encourage breast milk feeding/donor milk
- General recommendation: WHO and most paediatric nutrition bodies recommend breastfeeding exclusively for 6 months, with continued breastfeeding to 2 years alongside complementary foods
- Maternal supplementation: 200–300 mg DHA/day during pregnancy and lactation; oily fish (salmon, mackerel, sardines) 2–3 times/week
🎯 High-Yield Exam Facts
These are the facts that appear repeatedly across NEET PG, USMLE, AIIMS and FMGE papers.
- 🔴 DHA (22:6 ω3) is the key fatty acid in breast milk for infant brain and retinal development — the direct answer to the MCQ; present preformed in breast milk because neonates cannot synthesise it efficiently
- 🔴 The two truly essential fatty acids are Linoleic acid (LA, 18:2 ω6) and Alpha-linolenic acid (ALA, 18:3 ω3) — only these cannot be synthesised at all by humans
- 🔴 DHA makes up ~50% of fatty acids in photoreceptor outer segments and ~15–20% in cerebral cortex — explains visual and cognitive deficits in deficiency
- 🔴 Δ6-desaturase is the rate-limiting enzyme in both omega-3 and omega-6 long-chain PUFA synthesis — inhibited by trans fats, alcohol, zinc deficiency, and high omega-6:omega-3 ratio
- 🔴 EFA deficiency causes scaly dermatitis, alopecia, poor wound healing, and growth failure — the classic deficiency syndrome; think TPN without fat emulsion
- 🟠 DHA is derived from ALA via EPA — the pathway: ALA → (Δ6-desaturase) → stearidonic acid → EPA → (elongation + Δ6-desaturase + peroxisomal β-oxidation) → DHA
- 🟠 Mead acid (20:3 ω9) / Arachidonic acid ratio > 0.4 = EFA deficiency (Holman ratio) — Mead acid rises because ω9 oleic acid is used as an alternative substrate
- 🟠 Arachidonic acid (AA, 20:4 ω6) is also present in breast milk — functionally important for infant development alongside DHA; also conditionally essential in neonates
- 🟠 EPA (Eicosapentaenoic acid, 20:5 ω3) is NOT the answer — EPA is an omega-3 like DHA, but DHA is the dominant structural fatty acid in the brain and retina; EPA is more important in cardiovascular and anti-inflammatory contexts
- 🟡 Palmitic acid is the most abundant saturated fatty acid in breast milk but is NOT essential — the body can synthesise it de novo from acetyl-CoA; it provides energy but is not structurally indispensable for brain development
- 🟡 Linoleic acid is “essential” by definition but is NOT the exam answer here — the question asks about the specific fatty acid in breast milk required for NORMAL GROWTH of a child; DHA’s role in neurodevelopment is the specifically targeted concept
- 🟡 Fish oil is the richest dietary source of preformed DHA and EPA — oily fish (salmon, mackerel, herring, sardines, anchovies); vegetarian sources provide only ALA (inefficiently converted to DHA)
- 🟡 Trans fatty acids inhibit Δ6-desaturase — industrial hydrogenation produces trans fats that competitively inhibit the desaturation step; another reason why trans fat-rich diets impair DHA synthesis
🧠 Mnemonics & Memory Tricks
Mnemonic: “LADE — the two Essential fatty acids”
Stands for: Linoleic acid (ω6) Alpha-linolenic acid (ω3) are Diet-Essential
Use it for: Instantly recalling that ONLY LA and ALA are truly essential fatty acids
Mnemonic: “DHA = Developing Head Acid“
Use it for: Remembering that DHA is specifically required for brain (head) development in neonates — the reason it’s critical in breast milk
Mnemonic: “SINED for the omega-3 pathway”
Stands for: Stearidonic → Icosatetrenoic → (Δ5-desaturase) → EPA → (Elongation) → DHA
Use it for: Tracing the key steps from ALA to DHA without getting lost in the intermediate names
Mnemonic: “Fish are SMART“
Stands for: Fish oils contain DHA for Synapses, Myelin, Axons, Retinal photoreceptors, and Thinking (cognition)
Use it for: Remembering the multiple roles of DHA in the nervous system and why fish consumption benefits neurodevelopment
⚠️ Common Mistakes Students Make
❌ Mistake: “Linoleic acid is the answer because it is the classical essential fatty acid”
✅ Reality: While linoleic acid IS essential by biochemical definition, the question specifically asks about the fatty acid in breast milk required for normal growth of the child — this clinical context points to DHA, whose role in brain development is the specifically examined concept
📝 Exam trap: Read the stem carefully — “required for normal growth” with an infant context = DHA; “essential fatty acid deficiency with scaly skin” = think LA deficiency
❌ Mistake: “EPA is interchangeable with DHA for brain development”
✅ Reality: EPA (20:5 ω3) and DHA (22:6 ω3) are both omega-3 LC-PUFAs but serve very different roles — EPA is primarily anti-inflammatory (precursor to Series 3 prostaglandins and thromboxanes, Series 5 leukotrienes); DHA is primarily structural in the brain and retina
📝 Exam trap: Questions may give EPA and DHA as options — DHA is the answer for brain/retinal/infant development; EPA is the answer for cardiovascular/anti-inflammatory contexts
❌ Mistake: “DHA can be adequately synthesised by newborns from ALA in formula”
✅ Reality: Neonatal Δ6-desaturase activity is markedly immature, making conversion of ALA → DHA inefficient — preformed DHA in breast milk is essential; formula must be supplemented
📝 Exam trap: Questions about why breastfeeding is superior to formula may test this enzymatic immaturity concept
❌ Mistake: “Palmitic acid is essential because it is the most abundant fatty acid in breast milk”
✅ Reality: Abundance does not equal essentiality — palmitic acid (16:0) is the most abundant saturated fatty acid synthesised endogenously by the body from acetyl-CoA via fatty acid synthase; it is NOT essential
📝 Exam trap: “Most abundant fatty acid in breast milk” = palmitic acid/oleic acid; “most important for infant brain development” = DHA — these are different questions
❌ Mistake: “ALA and DHA are the same thing”
✅ Reality: ALA (18:3 ω3) is the short-chain essential precursor; DHA (22:6 ω3) is the long-chain product — both are omega-3 but structurally and functionally distinct; ALA is in plant foods (flaxseed, walnuts); DHA is preformed in fish and breast milk
📝 Exam trap: Questions listing both ALA and DHA — ALA = essential precursor; DHA = functionally critical in brain/retina; not interchangeable in MCQ contexts
🔗 How This Topic Connects to Others
- Eicosanoids (Prostaglandins, Thromboxanes, Leukotrienes) — Arachidonic acid (AA, ω6) is the precursor to the Series 2 prostaglandins and Series 4 leukotrienes; EPA (ω3) competes with AA to produce less inflammatory Series 3 and Series 5 eicosanoids — directly relevant to pharmacology of NSAIDs, aspirin, and fish oil supplements
- Beta-oxidation of Fatty Acids — The final step in DHA synthesis occurs in peroxisomes (not mitochondria) via β-oxidation of the 24-carbon intermediate — connects to peroxisomal disorders (Zellweger syndrome, where DHA synthesis is impaired)
- TPN and Nutritional Deficiencies — EFA deficiency is a classic complication of fat-free TPN; connects to clinical nutrition, critical care, and the rationale for lipid emulsions in parenteral nutrition
- Neonatal Physiology & Breastfeeding — DHA content of breast milk underpins the biochemical basis of breastfeeding superiority over formula; connects to paediatrics, lactation physiology, and WHO feeding guidelines
- Lipid Metabolism Disorders — Peroxisomal disorders (Zellweger spectrum) impair DHA synthesis; understanding DHA synthesis connects to the clinical features of these rare but exam-relevant disorders
- Cardiovascular Pharmacology — Omega-3 fatty acids (fish oil, EPA + DHA) are used clinically for hypertriglyceridaemia and have anti-arrhythmic and anti-platelet effects — connects to pharmacology and cardiology
❓ The MCQ That Started This — Fully Explained
Question: Essential fatty acid present in breast milk which is required for normal growth of child is:
- A. Linoleic acid
- B. Palmitic acid
- C. Docosahexaenoic acid (DHA)
- D. EPA
✅ Correct Answer: C. Docosahexaenoic acid (DHA)
Why correct: DHA (22:6 ω3) is present preformed in human breast milk and is the dominant structural omega-3 fatty acid in the developing infant brain (15–20% of cortical fatty acids) and retinal photoreceptors (~50% of photoreceptor fatty acids). Neonatal Δ6-desaturase activity is too immature to efficiently convert ALA to DHA, making breast milk DHA an indispensable nutritional source for normal neurodevelopment and visual acuity in infancy.
Why A is wrong: Linoleic acid (LA, 18:2 ω6) is the classical “essential” fatty acid (cannot be synthesised by humans), but the question specifically targets the fatty acid in breast milk critical for infant growth and development — which is the functional, neurodevelopmentally active DHA. LA deficiency causes skin and immune problems but is not the specific brain-growth fatty acid being tested here.
Why B is wrong: Palmitic acid (16:0) is a saturated fatty acid that the body synthesises de novo from acetyl-CoA via fatty acid synthase — it is not essential. While it is abundant in breast milk (and positioned at the sn-2 position of triglycerides to aid absorption), it provides energy rather than being structurally indispensable for brain development.
Why D is wrong: EPA (Eicosapentaenoic acid, 20:5 ω3) is an omega-3 LC-PUFA like DHA but serves primarily anti-inflammatory roles (precursor to Series 3 eicosanoids). It is present in breast milk in very small amounts and is not the specific fatty acid associated with infant brain and retinal structural development — DHA is.
📝 Test Your Understanding — 5 Practice MCQs
Q1. Which enzyme is the rate-limiting step in the synthesis of DHA from alpha-linolenic acid?
- A. Δ5-desaturase
- B. Δ9-desaturase
- C. Δ6-desaturase
- D. Fatty acid elongase
✅ **C. Δ6-desaturase** — This enzyme catalyses the first step in the conversion of ALA to stearidonic acid (and LA to GLA) and is the rate-limiting enzyme in long-chain PUFA synthesis. It is inhibited by trans fatty acids, alcohol, zinc deficiency, and excess omega-6 fatty acids competing for the same enzyme.
Q2. A 35-year-old man is maintained on total parenteral nutrition (TPN) without a lipid emulsion for 6 weeks following major bowel surgery. He develops a scaly, erythematous rash over his trunk and extremities with associated hair loss. Laboratory tests would most likely show:
- A. Elevated Mead acid:arachidonic acid ratio > 0.4
- B. Elevated DHA:EPA ratio > 3
- C. Reduced palmitic acid in plasma
- D. Elevated linoleic acid in plasma
✅ **A. Elevated Mead acid:arachidonic acid ratio > 0.4** — This is the Holman ratio, the biochemical marker of essential fatty acid deficiency. When LA is absent, Δ6-desaturase uses oleic acid (ω9) as an alternative substrate to produce Mead acid (20:3 ω9). An elevated Mead acid:AA ratio > 0.4 is diagnostic of EFA deficiency. The clinical picture (scaly dermatitis + alopecia + prolonged fat-free TPN) is classic.
Q3. A premature infant born at 28 weeks gestation is at highest risk for deficiency of which of the following compared to a full-term infant?
- A. Palmitic acid
- B. Cholesterol
- C. DHA and Arachidonic acid
- D. Stearic acid
✅ **C. DHA and Arachidonic acid** — The primary accumulation of DHA and AA in the fetal brain occurs during the **third trimester** of pregnancy. A 28-week preterm infant misses most of this critical period of placental transfer and intrauterine brain lipid accumulation. Combined with immature desaturase enzyme activity, premature infants are especially vulnerable to LC-PUFA deficiency — hence the importance of DHA/AA-supplemented preterm formula or human breast milk.
Q4. A lactating mother is advised to include oily fish in her diet twice a week. The PRIMARY reason for this recommendation is:
- A. To increase the saturated fat content of breast milk for infant energy needs
- B. To increase breast milk DHA concentration for infant neurodevelopment
- C. To provide linoleic acid that the infant cannot obtain from any other source
- D. To replace EPA lost during lactation from maternal stores
✅ **B. To increase breast milk DHA concentration for infant neurodevelopment** — Breast milk DHA content directly reflects the mother’s dietary DHA intake. Oily fish are the richest preformed dietary source of DHA (and EPA). Maternal dietary supplementation with DHA raises breast milk DHA levels dose-dependently, providing the infant with more of this critical structural fatty acid for brain and retinal development during the postnatal period.
Q5. A 6-month-old formula-fed infant presents with reduced visual acuity and delayed developmental milestones. The formula used does not contain added DHA. The biochemical explanation is BEST described as:
- A. The infant lacks the enzyme to absorb long-chain fatty acids from the gut
- B. Neonatal Δ6-desaturase immaturity prevents efficient conversion of ALA to DHA, causing structural deficiency in retinal photoreceptors and the cerebral cortex
- C. Palmitic acid in formula competitively inhibits DHA receptor binding in the retina
- D. Formula lacks the carrier protein needed to transport DHA across the blood-brain barrier
✅ **B. Neonatal Δ6-desaturase immaturity prevents efficient conversion of ALA to DHA, causing structural deficiency in retinal photoreceptors and the cerebral cortex** — Even if the formula contains ALA (the precursor), the neonatal liver cannot efficiently convert it to DHA because Δ6-desaturase is functionally immature in the first months of life. Without preformed DHA, the infant’s retinal photoreceptors (which require DHA to constitute ~50% of their fatty acids) and developing cortex are structurally compromised, leading to reduced visual acuity and developmental delay — effects that may be partially irreversible.
📚 References & Further Reading
- Harper’s Illustrated Biochemistry — 32nd Edition; Chapter 21: Biosynthesis of Fatty Acids & Eicosanoids (Desaturation, Elongation, Essential FA); Chapter 23: Metabolism of Unsaturated Fatty Acids
- Lippincott’s Illustrated Reviews: Biochemistry — 7th Edition; Chapter 16: Fatty Acid, Ketone Body & Triacylglycerol Metabolism; Chapter 18: Phospholipid, Glycosphingolipid & Eicosanoid Metabolism
- Nelson Textbook of Pediatrics — 21st Edition; Chapter 57: Nutritional Requirements; Chapter 102: Disorders of Fatty Acid Oxidation
- Stryer’s Biochemistry — 9th Edition; Chapter 22: Fatty Acid Metabolism; Section on Essential Fatty Acids and Eicosanoids
- Innis SM. “Dietary omega-3 fatty acids and the developing brain.” Brain Research, 2008 — Key reference on DHA in infant neurodevelopment
- WHO/UNICEF Global Strategy for Infant and Young Child Feeding — 2003; Rationale for exclusive breastfeeding and complementary feeding recommendations
🚀 Ready to Master Biochemistry & Infant Nutrition?
You’ve just built a complete foundation in essential fatty acids, the omega-3 pathway, DHA’s role in infant brain development, and the clinical syndromes that arise when this system fails. This topic connects biochemistry directly to bedside paediatrics and clinical nutrition — exactly the integration that top-scoring candidates master.
medicalmcq.in has hundreds of free Biochemistry MCQs — each with detailed explanations just like this article.
When you’re ready to simulate real exam pressure, our Mock Test Series gives you timed, subject-wise and full-length tests with performance analytics — so you know exactly where to focus next.
